A Case of Myeloid Sarcoma following Allogeneic HSCT Presenting as Localized Hip Pain
AffiliationUniv Arizona, Tucson Coll Med
MetadataShow full item record
CitationShannon Zhang, Casey Charlton, Akshay Amaraneni, and Keri Maher, “A Case of Myeloid Sarcoma following Allogeneic HSCT Presenting as Localized Hip Pain,” Case Reports in Hematology, vol. 2019, Article ID 2674359, 3 pages, 2019. https://doi.org/10.1155/2019/2674359.
JournalCASE REPORTS IN HEMATOLOGY
RightsCopyright © 2019 Shannon Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractMyeloid sarcoma is a rare variant of acute myeloid leukemia (AML) which presents as an extramedullary soft tissue mass. Due to the rarity of this disease, along with nonspecific presenting symptoms, diagnosis can be delayed or missed without a high index of suspicion. In this case, we discuss a patient diagnosed with AML relapse in the form of myeloid sarcoma two years after allogeneic hematopoietic stem cell transplant (alloHSCT) for myelodysplastic syndrome (MDS) with the initial presentation for back pain misdiagnosed as spinal stenosis. This case report aims to help healthcare providers in recognizing the early signs and symptoms of this disorder as well as provide information in regards to treatment options and risk assessment.
NoteOpen access journal
VersionFinal published version
- Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
- Authors: Stölzel F, Hackmann K, Kuithan F, Mohr B, Füssel M, Oelschlägel U, Thiede C, Röllig C, Platzbecker U, Schetelig J, Illmer T, Schaich M, Seliger B, Hartmann A, Baretton G, Zietz C, Ehninger G, Schrock E, Bornhäuser M
- Issue date: 2012 Apr 15
- Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
- Authors: Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T
- Issue date: 2015 Nov
- Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.
- Authors: Lazzarotto D, Candoni A, Filì C, Forghieri F, Pagano L, Busca A, Spinosa G, Zannier ME, Simeone E, Isola M, Borlenghi E, Melillo L, Mosna F, Lessi F, Fanin R
- Issue date: 2017 Feb
- Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT).
- Authors: Trobaugh-Lotrario AD, Kletzel M, Quinones RR, McGavran L, Proytcheva MA, Hunger SP, Malcolm J, Schissel D, Hild E, Giller RH
- Issue date: 2005 Jan
- Sacral Myeloid Sarcoma Manifesting as Radiculopathy in a Pediatric Patient: An Unusual Form of Myeloid Leukemia Relapse.
- Authors: Rodrigues JR, Brito MJ, Pais RPF, Carvalho S
- Issue date: 2018